Pancreatic Cancer Research

ResearcherKanazawa UniversityActive in the last 2 years

Motoharu Seiki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3909-0782; OpenAlex author ID A5008902984. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Serum laminin γ2 monomer as a novel diagnostic and prognostic marker for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s44276-024-00116-z↗
  2. Mint3 depletion restricts tumor malignancy of pancreatic cancer cells by decreasing SKP2 expression via HIF-1. Co-author DOI 10.1038/s41388-020-01423-8↗
  3. Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer. Last author DOI 10.1038/cddis.2017.545↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Naohiko Koshikawa · 2 shared papers, 2017–2025 · strength 0.30
  2. Akihiro Seki · 1 shared paper, 2025 · strength 0.20
  3. Takeshi Terashima · 1 shared paper, 2025 · strength 0.20
  4. Taro Yamashita · 1 shared paper, 2025 · strength 0.20
  5. Masaki Miyazawa · 1 shared paper, 2025 · strength 0.20
  6. Makoto Ueno · 1 shared paper, 2025 · strength 0.20
  7. Shuichi Kaneko · 1 shared paper, 2020 · strength 0.11
  8. Takeharu Sakamoto · 1 shared paper, 2020 · strength 0.11
  9. Akane Kanamori · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.